Effect of cimetidine on granulocyte-macrophage colony formation by normal and chronic renal failure bone marrow cells  by Weinstein, Taly et al.
Kidney International, Vol. 26 (1984), pp. 741—743
Effect of cimetidine on granulocyte-macrophage colony
formation by normal and chronic renal failure
bone marrow cells
TALY WEINSTEIN, PNINA FISHMAN, BARUCH KLEIN, JOSEPH LEVI, and MEIR DJALDETTI
Departments of Medicine "B" and Nephrology, Hasharon Hospital, Petah-Tiqva, and Tel Aviv University Medical School, Tel Aviv, Israel
Effect of cimetidine on granulocyte-macrophage colony formation by
normal and chronic renal failure bone marrow cells. The effect of
cimetidine, an antihistaminic blocker of the H2 receptors, on the
development of granulocyte-macrophage colonies (GMC) was exam-
ined in vitro on bone marrow cells from healthy individuals and chronic
renal failure (CRF) patients. The drug caused a dose-dependent de-
crease in the number of GMC from bone marrow samples in both
healthy subjects and patients, being much more expressed in the latter
group. The addition of urea to bone marrow cultures of healthy subjects
increased the inhibition of colony formation caused by cimetidine
alone. CRF or control serum added to normal bone marrow cells
enhanced the colony growth which was significantly more expressed
when using a CRF serum sample.
Effet de Ia cimétidine sur Ia formation colonie de granulocytes-macro-
phages par de Ia moelle osseuse normale ou d'insuffisance rénale chro-
nique. L'effet de Ia cimétidine, un bloqueur anti-histaminique des
recepteurs H2, sur le développement de colonies de granulocytes-
macrophages (GMC) a été examine in vitro sur des cellules médullaires
osseuses provenant d'individus normaux et de malades en insuffisance
rénale chronique (CRF). Le médicament a entrainé une diminution
dose-dépendante du nombre de GMC dans les moelles osseuses des
sujets normaux et des malades bien plus prononcée chez les derniers.
L'addition d'urée aux cultures médullaires osseuses de sujets sains a
augmente l'inhibition de Ia formation des colonies due a Ia cimétidine
seule. Du serum CRF ou du serum contrOle ajoutés a des cellules
médullaires normales ont stimulé Ia croissance des colonies qui était
significativement plus prononcee en utilisant prClèvement de serum
CRF.
Cimitidine is an antihistaminic drug which antagonizes the
action of 4-methyihistamine by blocking the 112 receptors, as
demonstrated by Byron [1] for bone marrow stem cells. It is
currently in use for a variety of peptic diseases and hypersecre-
tory states. Several reports have described marrow suppression
and granulocytopenia associated with the use of cimetidine
[2—7]. Eridani, Johnston, and Villa [8] studied bone marrow of
a patient with cimetidine-induced granulocytopenia and found
that the drug inhibited colony growth. Fitchen and Koeffler [9]
studied marrow samples from healthy volunteers and patients
with cimetidine-associated neutropenia and found an inhibition
of colony growth induced by the drug.
In most reported cases, the bone marrow samples were
hypocellular and showed a maturation arrest of the granulocytic
series, suggesting a toxic effect at the level of committed stem
cells.
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Patients with renal failure were among the observed cases [8,
101 and were perhaps more prone to develop granulocytopenia.
We have had the opportunity to follow a patient with chronic
renal failure (CRF) treated with cimetidine for gastrointestinal
bleeding who developed neutropenia which disappeared after
discontinuing the drug.
The purpose of this work was to examine the in vitro effect of
cimetidine on the number of granulocyte-macrophage colonies
(GMC) from bone marrow cells of CRF patients in comparison
with bone marrow cells from healthy volunteers. In addition,
the effect of CRF serum, urea, and creatinine on the formation
of GMC by normal bone marrow cells was evaluated.
Methods
Bone marrow cells. Bone marrow cells (0.5 ml) were obtained
by sternal aspiration biopsy from eight healthy volunteers (age
range, 22 to 70 years) and eight CRF patients (age range,
between 18 and 70 years). In three the cause of the CRF was
chronic glomerulonephritis; in two, systemic lupus erythema-
tosus; in one, rapidly progressive glomerulonephritis, and in the
remaining two the cause was unknown. All patients were under
treatment with chronic hemodialysis for 1 to 5 years, sup-
plemented with vitamins and aluminium-hydroxide suspension.
The aspirate was layered on Ficoll-Hypaque gradient accord-
ing to the method of BØyum [11] to separate the mononuclear
cells.
Serum and drugs. Normal serum was obtained from healthy
volunteers and CRF serum was collected from the same pa-
tients from whom the bone marrow was obtained. Pooled serum
stored at —20°C was used throughout all experiments.
Cimetidine was used in pure powdered form (Teva, Jerusalem,
Israel), urea, and creatinine (Sigma, St. Louis, Missouri) all
were diluted to appropriate concentrations in McCoy 5A me-
dium (Gibco, New York).
Bone marrow culture. The number of colony-forming cells in
the bone marrow was assayed as previously described by Pike
and Robinson [12]. Briefly, 2 x l0 bone marrow cells were
plated at a final volume of I ml in 0.3% agar in McCoy's 5A
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medium with 15% fetal bovine serum (Flow Laboratories,
Irvine, Scotland). The source of colony-stimulating factor was
human placenta conditioned medium prepared according to
Burgess et al [13J at a concentration of 10%. In each experiment
three concentrations of cimetidine were used: 250, 500, and 750
g/ml. Culture dishes without the drug served as controls.
In addition, 200 mg% urea, 10 mg% creatinine, 10% serum, or
10% normal serum were added to the bone marrow cultures
derived from healthy volunteers. All plates were cultured for 7
days at 37°C in a humidified atmosphere containing 10% CO2.
Colonies of 40 or more cells were scored.
The Student's r test was used for the statistical analysis of the
results.
Results
Figure 1 shows the effect of cimetidine on the GMC produc-
tion by normal and CRF bone marrow cells. At a cimetidine
concentration of 250 g/ml, the GMC count in normal bone
marrow was similar to that of controls, while the number of
colonies in the CRF bone marrow showed a marked decrease to
30% as compared to controls (P < 0.001). At a concentration of
500 sg/ml, the number of colonies from normal bone marrow
was 68.9% of control, while that from CRF marrow was only
9 (P < 0.001). At a concentration of 750 g/ml the number of
GMC in normal marrow was suppressed to 42.7% of that in
controls, while in CRF marrow only to 5% (P <0.001).
Figure 2 presents the results after addition of 200 mg% of urea
to the cultures. It caused an inhibition of GMC formation in
normal bone marrow to 64.8% of controls (P < 0.001). The
addition of cimetidine at a concentration of 250 g/ml decreased
the number ofGMC, yet not significantly (P <0.15). Cimetidine
(500 sg/ml) and urea (200 mg%) caused a significant inhibition
of colony growth (P < 0.0005), while 750 ig/ml of cimetidine
with urea, created a complete inhibition.
Figure 3 shows a comparison of the effects of normal and
CRF serum on the formation of GMC by normal bone marrow
cells in the presence of cimetidine. In control cultures without
cimetidine, both sera significantly stimulated colony growth,
but CRF serum had a more pronounced stimulatory effect (P <
0.05). At all concentrations of cimetidine colony growth was not
inhibited but enhanced in the presence of both sera, although
not significantly. CRF serum had a greater effect than normal
serum, but the difference was not significant. The addition of 10
mg% of creatinine with or without cimetidine had no effect on
the production of GMC in the bone marrow of healthy subjects.
Discussion
In this study the effect of cimetidine on the production of
GMC by CRF bone marrow cells was compared to that of
normal bone marrow cells. The results showed an inhibition of
colony growth in the presence of cimetidine which was more
pronounced in CRF bone marrow.
It has been demonstrated by Fitchen and Koeffler [91 that
cimetidine inhibits colony growth in normal bone marrow in
vitro in a dose-dependent manner. A review of the literature on
cimetidine-induced granulocytopenia revealed cases of uremic
patients in whom this side effect was observed [8, 101. The
leukopenic effect of cimetidine was explained by Byron [11,
who showed that the histamine H2 receptor agonist 4-methyl-
histamine triggers the pluripotent stem cells of mouse bone
marrow from 0-0 to S-phase of the cell cycle. Because cimet-
idine is an antagonist of the 4-methyl-histamine, it is conceiv-
able that patients treated with cimetidine will be more prone to
develop leukopenia. If differentiation of progenitor cells in CRF
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shown a high level of colony-stimulating factor in serum sam-
ples of rats that underwent ureteral ligation. In addition, it has
been shown that during hemodialysis with cellophane mem-
branes, there was an immediate decrease in the number of
neutrophils in the peripheral blood [161. It is possible that the
granulocytopenia during hemodialysis is also a stimulator for
the production of colony-stimulating factor, to compensate for
the loss of cells.
Reprint requests to Professor M. Djaldetti, Department of Medicine
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patients is carried out via this pathway, their bone marrow
could be more sensitive to the inhibition by cimetidine. Since
cimetidine is excreted by the kidney, it is possible that in
patients with renal failure it accumulates to a higher level and
thus it has a more toxic effect.
Incubation of normal bone marrow with urea in the presence
of cimetidine caused a significant inhibition of colony growth.
Although it is difficult to deny an osmotic effect of urea, it is
conceivable that this effect is also present in vivo. On the other
hand, the addition of CRF serum to the culture induced a
significant stimulation of colony growth compared to normal
serum. It has been shown that normal serum is a stimulator of
colony growth [14]. It is possible that the additional stimulating
effect of CRF serum is due to a higher level of colony stimulat-
ing factor than in normal serum. Foster and Mirand [151 have
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